Hina Ismail¹, Raja Taha Yaseen Khan¹*, Ghous Bux Soomro³, Nasir Mehmood¹, Muhammad Ali Khalid¹, Ghazi Abrar¹, Nadir Ali¹, Reeaa Harjani¹, Abdul Wahid¹, Danish Kumar¹, Husnain Ali¹, Nasir Hassan Luck¹, Syed Haider Mehdi² and Abdaal Waseem Khan²

¹Department of Hepato-gastroenterology, Sindh Institute of Urology and Transplantation, SIUT, Karachi, Pakistan

*Corresponding Author: Raja Taha Yaseen Khan, Department of Hepato-gastroenterology, Sindh Institute of Urology and Transplantation, SIUT, Karachi, Pakistan.

Received: September 15, 2022; Published: November 08, 2022

Abstract

Hepatocellular carcinoma with portal vein thrombosis is rarely seen in young patients. Hepatitis B can lead to HCC with PVT in the absence of cirrhosis. However, it is uncommon in age less than 40 years. Here we present to you a case of an eight year old boy with a family history of hepatitis B who developed HCC with PVT.

Keywords: Hepatitis B; Hepatocellular Carcinoma; Portal Vein Thrombosis

References

1. Shirabe K., et al. “Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses”. Hepatology 14 (1991): 802-805.
2. DeLeve LD., et al. “Vascular disorders of the liver”. Hepatology 49 (2009): 1729-1764.
3. Korn Lertpipopmetha, Chirayu U Auewarakul. “High Incidence of Hepatitis B Infection-Associated Cirrhosis and Hepatocellular Carcinoma in the Southeast Asian Patients with Portal Vein Thrombosis”. BMC Gastroenterology 11 (2011): 66.
4. Yamanaka N and Okamoto E. “Conditions favoring long-term survival after hepatectomy for hepatocellular carcinomas”. Cancer Chemotherapy and Pharmacology 23 (1989): S83-S86.
5. Forner A., et al. “Hepatocellular carcinoma”. Lancet 379 (2012): 1245-1255
6. Fattovich G. “Natural history and prognosis of hepatitis B”. Seminars in Liver Disease 23 (2003): 47-58.
7. Bruix J and Sherman M. “Management of hepatocellular car-cinoma: an update”. Hepatology 53 (2011): 1020-1022.
8. Jordi Bruix and Morris Sherman. “Management of Hepatocellular Carcinoma”. Hepatology 5 (2005): 1208-1236.
9. Fattovich G. “Natural history of hepatitis B”. Journal of Hepatology 39 (2003): S50-58.
10. Hsu YS., et al. “Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B”. Hepatology 35 (2002): 1522-1527.
11. Huo TI., et al. “Seroclearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis”. Hepatology 28 (1998): 231-236.
12. Evans AA., et al. “Eight year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences”. Cancer Epidemiology, Biomarkers and Prevention 11 (2002): 369-376.
13. Siddique O., et al. “The importance of a multidisciplinary approach to hepatocellular carcinoma”. Journal of Multidisciplinary Healthcare 10 (2017): 95-100.
14. Llovet JM and Bruix J. “Novel advancements in the management of hepatocellular carcinoma in 2008”. Journal of Hepatology 48 (2008): S20-37.
15. Beasley RP. “Hepatitis B virus as the etiologic agent in hepatocellular carcinoma”. Hepatology 2 (1982): S21-26.
16. Khalid S., et al. “Frequency of Hereditary Thrombophilia: an AKUH experience”. JPMA 54 (2004): 427.
17. Ahmed I. “Prevalence of Hepatitis B and C Viral Infection Among Pregnant Women in Peshawar, Pakistan”. Hepatitis Monthly6 (2016): e36383.
18. Sogaard KK., et al. “Portal vein thrombosis; risk factors, clinical presentation and treatment”. BMC Gastroenterology 7 (2007): 34.
19. Amitrano L., et al. “Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis”. Journal of Hepatology 40 (2004): 736-741.
20. Lin CL and Kao JH. “Risk stratification for hepatitis B virus related hepatocellular carcinoma”. Journal of Gastroenterology and Hepatology 28 (2013): 10-17.
21. El-Serag HB and Rudolph KL. “Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis”. Gastroenterology 132 (2007): 2557-2576.
22. Wan DW., et al. “Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States”. American Journal of Gastroenterology 106 (2011): 1994-2000.
23. Reig M., et al. “BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update”. Journal of Hepatology3 (2022): 681-693.

Citation

Citation: Raja Taha Yaseen Khan., et al. “Hepatocellular Carcinoma with Portal Vein Thrombosis in an Eight Year Old Boy". Acta Scientific Gastrointestinal Disorders 5.12 (2022): 03-07.

Copyright

Copyright: © 2022 Raja Taha Yaseen Khan., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.